4.3 Article

Development and Validation of a Novel PPAR Signaling Pathway-Related Predictive Model to Predict Prognosis in Breast Cancer

Related references

Note: Only part of the references are listed.
Article Biochemical Research Methods

ImmuCellAI-mouse: a tool for comprehensive prediction of mouse immune cell abundance and immune microenvironment depiction

Ya-Ru Miao et al.

Summary: ImmuCellAI-mouse is an accurate tool for predicting mouse immune cell abundance, utilizing gene expression data and a hierarchical strategy to accurately predict most immune cell types, revealing dynamic changes in immune cell infiltration in a mouse tumor dataset.

BIOINFORMATICS (2022)

Article Biotechnology & Applied Microbiology

Fatty acid beta-oxidation promotes breast cancer stemness and metastasis via the miRNA-328-3p-CPT1A pathway

Feng Zeng et al.

Summary: MiR-328-3p is significantly downregulated in breast cancer, especially in patients with metastasis. The miR-328-3p/CPT1A/fatty acid beta-oxidation/stemness axis has been shown to be responsible for breast cancer metastasis. This study suggests that miR-328-3p could be a potential therapeutic target for breast cancer patients with metastasis.

CANCER GENE THERAPY (2022)

Article Oncology

Construction and Validation of Angiogenesis-Related Prognostic Risk Signature to Facilitate Survival Prediction and Biomarker Excavation of Breast Cancer Patients

Yingkun Xu et al.

Summary: This study aims to explore the potential mechanism of angiogenesis in breast cancer (BRCA) and construct a risk model for predicting prognosis. Through bioinformatics analysis, a risk model consisting of seven angiogenesis-related genes in BRCA was established, and its accuracy was validated. The findings provide valuable data and clues for future studies on angiogenesis in BRCA.

JOURNAL OF ONCOLOGY (2022)

Article Cell Biology

Breast cancer-associated skeletal muscle mitochondrial dysfunction and lipid accumulation is reversed by PPARG

Hannah E. Wilson et al.

Summary: The study showed that breast cancer-derived factors affect skeletal muscle mitochondrial function and lipid accumulation via different mechanisms, with the former likely being altered through repression of PPAR-mediated transcription, and the latter through transcription-independent functions of PPARG.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2021)

Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

Preclinical development of CD126 CAR-T cells with broad antitumor activity

Ameet K. Mishra et al.

Summary: CD126 is expressed by various tumors and CAR-T cells targeting CD126 show efficient killing of tumor cells. Binding of soluble interleukin-6 receptor (sIL-6R) by CAR-T cells can mitigate cytokine release syndrome. CD126 provides a novel therapeutic target for CAR-T cells for many tumors with low toxicity risk.

BLOOD CANCER JOURNAL (2021)

Review Oncology

Association between BRCA mutational status and survival in patients with breast cancer: a systematic review and meta-analysis

Miao Liu et al.

Summary: The meta-analysis showed that breast cancer patients with BRCA 1 or BRCA 2 mutations had poor survival outcomes. BRCA 1 mutation was associated with lower overall survival, while BRCA 2 mutation was associated with lower disease-free survival and breast cancer-specific survival. Subgroup analysis revealed poorer outcomes in patients with BRCA mutations, particularly in those with triple negative breast cancer.

BREAST CANCER RESEARCH AND TREATMENT (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Medicine, Research & Experimental

miR-22-3p/PGC1β Suppresses Breast Cancer Cell Tumorigenesis via PPARγ

Xuehui Wang et al.

Summary: miR-22-3p plays a suppressive role in breast cancer, inhibiting proliferation and migration of breast cancer cells by regulating the PPAR gamma pathway.

PPAR RESEARCH (2021)

Article Medicine, Research & Experimental

Identification of a Potential PPAR-Related Multigene Signature Predicting Prognosis of Patients with Hepatocellular Carcinoma

Wenfang Xu et al.

Summary: This study identified three genes from the PPAR signaling pathway that could effectively, independently, and applicatively predict the prognosis of HCC. The three-gene signature showed a high prognostic ability and could distinguish high-risk and low-risk patients with poor prognosis for HCC.

PPAR RESEARCH (2021)

Article Oncology

Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer

Wanting Shao et al.

Summary: The study aimed to investigate the expression of liver X receptors alpha/beta in primary breast cancer tissues and analyze its correlations with clinicopathological parameters, including patient survival. The results showed that LXR was frequently localized in both nuclei and cytoplasms of breast cancer cells, with stronger staining in nuclei. Cytoplasmic LXR was significantly correlated with poor survival and appeared as an independent marker of poor prognosis in early stage breast cancer.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)

Article Biotechnology & Applied Microbiology

A New Survival Model Based on Cholesterol Biosynthesis-Related Genes for Prognostic Prediction in Clear Cell Renal Cell Carcinoma

Xiaochen Qi et al.

Summary: This study identified 9 CBRGs associated with the prognosis of patients with renal clear cell carcinoma, and established a new survival model that can predict prognosis more accurately.

BIOMED RESEARCH INTERNATIONAL (2021)

Article Oncology

High CYP27A1 expression is a biomarker of favorable prognosis in premenopausal patients with estrogen receptor positive primary breast cancer

Maria Inasu et al.

Summary: High expression of CYP27A1 was associated with reduced distant recurrence-free survival events in ER+ breast cancer patients. In vitro studies showed that 27HC treatment effectively inhibited ER+ breast cancer cell proliferation under lipid-depleted conditions.

NPJ BREAST CANCER (2021)

Article Oncology

High prevalence of APOA1/C3/A4/A5 alterations in luminal breast cancers among young women in East Asia

Ching-Hung Lin et al.

Summary: The incidence of breast cancer among women under 50 years old in East Asia has been rapidly increasing, with unique genetic alterations identified in these tumors such as copy number loss in the APOA1/C3/A4/A5 gene cluster. This genetic change may have immunomodulatory effects on the tumor microenvironment and play various roles in the tumor biology of East Asian patients.

NPJ BREAST CANCER (2021)

Article Biochemistry & Molecular Biology

CPT1A and fatty acid β-oxidation are essential for tumor cell growth and survival in hormone receptor-positive breast cancer

Nidhi Jariwala et al.

Summary: The amplification of chromosome 11q13-14 and overexpression of CPT1A are associated with aggressive luminal breast tumors, tumor proliferation, and poor prognosis. Inhibition of FAO, an essential process involving CPT1A, is effective in preventing tumor growth and promoting apoptosis in luminal breast cancer cells. These findings suggest that targeting FAO may be a potential therapeutic strategy for HR+ breast cancer treatment.

NAR CANCER (2021)

Article Oncology

Cancer statistics, 2020

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Article Medicine, Research & Experimental

A New Prognostic Risk Model Based on PPAR Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma

Yingkun Xu et al.

PPAR RESEARCH (2020)

Review Biochemistry & Molecular Biology

Targeting cancer stem cell pathways for cancer therapy

Liqun Yang et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Article Oncology

Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence

Raoul Charles Coombes et al.

CLINICAL CANCER RESEARCH (2019)

Article Medicine, General & Internal

Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer

Fabrice Andre et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Review Biochemistry & Molecular Biology

PPARs as Nuclear Receptors for Nutrient and Energy Metabolism

Fan Hong et al.

MOLECULES (2019)

Article Medicine, Research & Experimental

Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy

Zheqiong Tan et al.

THERANOSTICS (2018)

Article Medicine, General & Internal

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

P. Schmid et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Oncology

Prognostic impact of metastatic pattern in stage IV breast cancer at initial diagnosis

Bernardo Amadeo Leone et al.

BREAST CANCER RESEARCH AND TREATMENT (2017)

Article Oncology

Impact of 27-hydroxylase (CYP27A1) and 27-hydroxycholesterol in breast cancer

Siker Kimbung et al.

ENDOCRINE-RELATED CANCER (2017)

Article Biochemistry & Molecular Biology

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses

Zefang Tang et al.

NUCLEIC ACIDS RESEARCH (2017)

Article Multidisciplinary Sciences

A subcellular map of the human proteome

Peter J. Thul et al.

SCIENCE (2017)

Article Multidisciplinary Sciences

A pathology atlas of the human cancer transcriptome

Mathias Uhlen et al.

SCIENCE (2017)

Article Oncology

Risk Factors of Female Breast Cancer in Vietnam: A Case-Control Study

Phuong Dung (Yun) Trieu et al.

CANCER RESEARCH AND TREATMENT (2017)

Article Oncology

CYP27A1 Loss Dysregulates Cholesterol Homeostasis in Prostate Cancer

Mahmoud A. Alfaqih et al.

CANCER RESEARCH (2017)

Review Oncology

Global Cancer Incidence and Mortality Rates and Trends-An Update

Lindsey A. Torre et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2016)

Review Biotechnology & Applied Microbiology

Reprogramming cancer cells: overview & current progress

Kian Lam Lim et al.

EXPERT OPINION ON BIOLOGICAL THERAPY (2016)

Article Biotechnology & Applied Microbiology

Comprehensive analyses of tumor immunity: implications for cancer immunotherapy

Bo Li et al.

GENOME BIOLOGY (2016)

Editorial Material Multidisciplinary Sciences

Untitled

Chris Woolston

NATURE (2015)

Article Multidisciplinary Sciences

Tissue-based map of the human proteome

Mathias Uhlen et al.

SCIENCE (2015)

Editorial Material Genetics & Heredity

The Cancer Genome Atlas Pan-Cancer analysis project

John N. Weinstein et al.

NATURE GENETICS (2013)

Article Gastroenterology & Hepatology

Intestinal mucosal MMP-1 - a prognostic factor in colon cancer

Marcus Langenskiold et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2013)

Article Multidisciplinary Sciences

27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology

Erik R. Nelson et al.

SCIENCE (2013)

Review Physiology

Macrophages, Inflammation, and Insulin Resistance

Jerrold M. Olefsky et al.

ANNUAL REVIEW OF PHYSIOLOGY (2010)

Article Endocrinology & Metabolism

Liver X Receptor Ligands Suppress Ubiquitination and Degradation of LXRα by Displacing BARD1/BRCA1

Kang Ho Kim et al.

MOLECULAR ENDOCRINOLOGY (2009)

Review Biochemistry & Molecular Biology

Tumor metastasis: mechanistic insights and clinical challenges

Patricia S. Steeg

NATURE MEDICINE (2006)

Article Multidisciplinary Sciences

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

A Subramanian et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)